Profile

Ravi Nandan Singh, Ph.D.Wake Forest School of Medicine

Ravi Nandan Singh, Ph.D.

Assistant Professor,
Redox Biology & Medicine Ctr

Contact Information

Academic: 336-713-4434 | Department: 336-713-4434

Email: rasingh@wakehealth.edu

Additional Languages

Spanish

Education & Training

  • B.A., Harvard University, 1995
  • Ph.D., Univ of London School Of Pharmacy-United Kingdom, 2008
  • Fellowship, Cell Biology, WFU School of Medicine, 2012

Memberships

  • Am Assn for Cancer Research
  • Sigma Xi - Research Society
Ravi Nandan Singh, Ph.D.

Ravi Nandan Singh, Ph.D.

Assistant Professor, Cancer Biology
Redox Biology & Medicine Ctr

Research Interests

Nanotubes, Carbon; Nanoparticles; Phototherapy; Neoplastic Stem Cells; Iron Chelating Agents
More »

Contact Information

Academic: 336-713-4434 | Department: 336-713-4434

Email: rasingh@wakehealth.edu

Recent Publications

Prostate-specific membrane antigen-targeted liposomes specifically deliver the Zn(2+) chelator TPEN inducing oxidative stress in prostate cancer cells. Stuart CH, Singh R, Smith TL, D'Agostino R Jr, Caudell D, Balaji KC, Gmeiner WH.. Nanomedicine (Lond). 2016;11(10):1207-1222.

Photothermal therapy of glioblastoma multiforme using multiwalled carbon nanotubes optimized for diffusion in extracellular space. Eldridge BN, Bernish BW, Fahrenholtz CD, Singh R.. ACS Biomater Sci Eng. 2016;2(6):963-976.

Systemic delivery of silver nanoparticles and targeting of the folate receptor alpha for the treatment of triple-negative breast cancer [abstract]. Swanner JL, Fahrenholtz CD, Singh RN.. Mol Cancer Res. 2016;14(2 Suppl):B04.

Self-assembling platinum-acridine loaded carbon nanotubes for triple-negative breast cancer chemotherapy [abstract]. Fahrenholtz CD, Ding S, Bernish BW, Wright M, Bierbach U, Singh RN.. Mol Cancer Res. 2016;14(2 Suppl):B05.

Design and cellular studies of a carbon nanotube-based delivery system for a hybrid platinum-acridine anticancer agent. Fahrenholtz CD, Ding S, Bernish BW, Wright ML, Zheng Y, Yang M, Yao X, Donati GL, Gross MD, Bierbach U, Singh R.. J Inorg Biochem. 2016;():.

Differential cytotoxic and radiosensitizing effects of silver nanoparticles on triple-negative breast cancer and non-triple-negative breast cells. Swanner J, Mims J, Carroll DL, Akman SA, Furdui CM, Torti SV, Singh RN.. Int J Nanomedicine. 2015;10():3937-3953.

Targeting breast cancer with sugar-coated carbon nanotubes. Fahrenholtz CD, Hadimani M, King SB, Torti SV, Singh R.. Nanomedicine (Lond). 2015;10(16):2481-2497.

Improved local and systemic anti-tumor efficacy for irreversible electroporation in immunocompetent versus immunodeficient mice. Neal RE II, Rossmeisl JH Jr, Robertson JL, Arena CB, Davis EM, Singh RN, Stallings J, Davalos RV.. PLoS One. 2013;8(5):e64559.

Carbon nanotubes for thermal therapy. Singh RN, Alexander P, Burke AR, Torti FM, Torti SV. In: Cho SH, Krishnan S, eds. Cancer nanotechnology: principles and applications in radiation oncology. Boca Raton (FL): CRC Press/Taylor & Francis;2013: 205-228.

Nanoparticles for cancer imaging: the good, the bad, and the promise. Chapman S, Dobrovolskaia M, Farahani K, Goodwin A, Joshi A, Lee H, Meade T, Pomper M, Ptak K, Rao J, Singh R, Sridhar S, Stern S, Wang A, Weaver JB, Woloschak G, Yang L.. Nano Today. 2013;8(5):454-460.

Carbon nanotubes in hyperthermia therapy. Singh R, Torti SV.. Adv Drug Deliv Rev. 2013;65(15):2045-2060.

The resistance of breast cancer stem cells to conventional hyperthermia and their sensitivity to nanoparticle-mediated photothermal therapy. Burke AR, Singh RN, Carroll DL, Wood JCS, D'Agostino RB Jr, Ajayan PM, Torti FM, Torti SV.. Biomaterials. 2012;33(10):2961-2970.

Heat localization for targeted tumor treatment with nanoscale near-infrared radiation absorbers. Xie B, Singh R, Torti FM, Keblinski P, Torti S.. Phys Med Biol. 2012;57(18):5765-5775.

Targeting cancer stem cells with nanoparticle-enabled therapies. Burke AR, Singh RN, Carroll DL, Torti FM, Torti SV.. J Mol Biomarkers Diagn. 2012;2012(S:8):003.

Determinants of the thrombogenic potential of multiwalled carbon nanotubes. Burke AR, Singh RN, Carroll DL, Owen JD, Kock ND, D'Agostino R Jr, Torti FM, Torti SV.. Biomaterials. 2011;32(26):5970-5978.

Development of iron-containing multiwalled carbon nanotubes for MR-guided laser-induced thermotherapy. Ding X, Singh R, Burke A, Hatcher H, Olson J, Kraft RA, Schmid M, Carroll D, Bourland JD, Akman S, Torti FM, Torti SV.. Nanomedicine (Lond). 2011;6(8):1341-1352.

Treatment of breast cancer through the application of irreversible electroporation using a novel minimally invasive single needle electrode. Neal RE II, Singh R, Hatcher HC, Kock ND, Torti SV, Davalos RV.. Breast Cancer Res Treat. 2010;123(1):295-301.

Designer adenoviruses for nanomedicine and nanodiagnostics. Singh R, Kastarelos K.. Trends Biotechnol. 2009;27(4):220-229.

Synthetic and natural iron chelators: therapeutic potential and clinical use. Hatcher HC, Singh RN, Torti FM, Torti SV.. Future Med Chem. 2009;1(9):1643-1670.

Long-term survival following a single treatment of kidney tumors with multiwalled carbon nanotubes and near-infrared radiation. Burke A, Singh R, Kraft RA, Levi-Polyachenko N, Hatcher HC, D'Agostino R Jr, Kock ND, Carroll DL, Akman S, Torti FM, Torti SV, et al.. Proc Natl Acad Sci U S A. 2009;106(31):12897-902.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Assistant Professor, Cancer Biology

Ravi Nandan Singh, Ph.D.

Ravi Nandan Singh, Ph.D.

Assistant Professor, Cancer Biology
Redox Biology & Medicine Ctr

Quick Reference

Request an Appointment
New Patients

336-716-WAKE
888-716-WAKE

Existing patients may contact the clinic directly.
Find a Doctor Ways to Give
Comprehensive Cancer Centers National Designation is RenewedMagnet Hospital RecognitionConsumer Choice2015 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.